Siheung-si, South Korea

Ok Kyoung Choi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Boryung Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ok Kyoung Choi. Retrieved from https://idiyas.com/inventor/ok-kyoung-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ok Kyoung Choi: Innovator in PI3K Inhibitor Development

Introduction

Ok Kyoung Choi is a notable inventor based in Siheung-si, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as PI3K inhibitors. Her innovative approach has the potential to simplify processes in drug manufacturing.

Latest Patents

Ok Kyoung Choi holds a patent for a method of preparing a compound as a PI3K inhibitor. This invention focuses on reducing process steps and shortening reaction times, enabling reactions to occur under milder conditions. The method not only simplifies the preparation process but also enhances the feasibility of industrial mass production.

Career Highlights

Choi is currently associated with Boryung Corporation, where she applies her expertise in pharmaceutical innovation. Her work has been instrumental in advancing the company's research and development efforts in the field of oncology.

Collaborations

Ok Kyoung Choi collaborates with talented colleagues, including Yong Ho Sun and Joon Kwang Lee. These partnerships foster a dynamic environment for innovation and contribute to the success of their projects.

Conclusion

Ok Kyoung Choi's contributions to the development of PI3K inhibitors exemplify her commitment to advancing pharmaceutical science. Her innovative methods promise to enhance drug production efficiency and effectiveness.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…